American Oriental Bioengineering, Inc. (AOBI)

AOBI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Oct 17, 2025	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	0	13	44	189	364	531
Market Cap Growth	-100.00%	-69.69%	-76.66%	-48.21%	-31.45%	-36.04%
Enterprise Value	-	54	84	219	378	437
Last Close Price	0.00	170.34	561.92	2404.81	4659.32	6803.61
PE Ratio	-	-	-	13.39	8.79	11.29
PS Ratio	-	0.09	0.21	0.62	1.23	2.01
PB Ratio	-	0.04	0.12	0.44	0.92	1.52
P/TBV Ratio	-	0.08	0.21	0.84	1.93	3.71
P/FCF Ratio	-	-	-	96.05	23.23	317.33
P/OCF Ratio	-	-	1.47	22.97	13.21	7.10
EV/Sales Ratio	-	0.37	0.40	0.72	1.28	1.65
EV/EBITDA Ratio	-	-	8.30	5.09	5.31	5.11
EV/EBIT Ratio	-	-	-	7.22	6.44	5.77
EV/FCF Ratio	-	-	-	111.68	24.13	261.22
Debt / Equity Ratio	0.33	0.17	0.30	0.29	0.32	0.35
Debt / EBITDA Ratio	-	-	11.39	2.85	1.77	1.44
Debt / FCF Ratio	-	-	-	62.48	8.05	73.63
Asset Turnover	0.26	0.29	0.36	0.52	0.54	0.60
Inventory Turnover	3.51	5.11	7.20	13.18	11.22	7.19
Quick Ratio	0.24	0.50	0.74	4.85	3.16	2.35
Current Ratio	0.51	0.90	1.16	5.55	3.79	2.92
Return on Equity (ROE)	-28.22%	-16.85%	-16.92%	3.41%	11.09%	14.20%
Return on Assets (ROA)	-6.30%	-6.79%	-0.24%	3.20%	6.65%	10.67%
Return on Invested Capital (ROIC)	-12.77%	-13.38%	-0.51%	4.12%	10.66%	21.24%
Return on Capital Employed (ROCE)	-15.50%	-16.20%	-0.60%	5.40%	11.10%	15.70%
Earnings Yield	-103430363.64%	-447.44%	-153.21%	7.47%	11.37%	8.86%
FCF Yield	-63274625.00%	-514.23%	-45.24%	1.04%	4.30%	0.32%
Buyback Yield / Dilution	4.50%	-2.37%	1.18%	15.19%	-8.55%	-15.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.